Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth

Bai, 2012, Yes-associated protein regulates the hepatic response after bile duct ligation, Hepatology, 56, 1097, 10.1002/hep.25769

Barrett, 1982, L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L, Biochem. J., 201, 189, 10.1042/bj2010189

Camargo, 2007, YAP1 increases organ size and expands undifferentiated progenitor cells, Curr. Biol., 17, 2054, 10.1016/j.cub.2007.10.039

Chan, 2001, p300/CBP proteins: HATs for transcriptional bridges and scaffolds, J. Cell Sci., 114, 2363, 10.1242/jcs.114.13.2363

Chen, 2004, Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes, J. Biol. Chem., 279, 30800, 10.1074/jbc.M400154200

de Boer, 2003, Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice, Proc. Natl. Acad. Sci. USA, 100, 7480, 10.1073/pnas.1332608100

Del Re, 2013, Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury, J. Biol. Chem., 288, 3977, 10.1074/jbc.M112.436311

Dong, 2007, Elucidation of a universal size-control mechanism in Drosophila and mammals, Cell, 130, 1120, 10.1016/j.cell.2007.07.019

Dupont, 2011, Role of YAP/TAZ in mechanotransduction, Nature, 474, 179, 10.1038/nature10137

Galli, 2015, YAP drives growth by controlling transcriptional pause release from dynamic enhancers, Mol. Cell, 60, 328, 10.1016/j.molcel.2015.09.001

Hata, 2012, A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents, J. Biol. Chem., 287, 22089, 10.1074/jbc.M111.334714

He, 2012, PRC2 directly methylates GATA4 and represses its transcriptional activity, Genes Dev., 26, 37, 10.1101/gad.173930.111

Heallen, 2011, Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size, Science, 332, 458, 10.1126/science.1199010

Heallen, 2013, Hippo signaling impedes adult heart regeneration, Development, 140, 4683, 10.1242/dev.102798

Heidenreich, 2013, Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association, Circ. Heart Fail., 6, 606, 10.1161/HHF.0b013e318291329a

Huang, 2005, The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP, Cell, 122, 421, 10.1016/j.cell.2005.06.007

Jiao, 2014, A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer, Cancer Cell, 25, 166, 10.1016/j.ccr.2014.01.010

Kajstura, 1998, Myocyte proliferation in end-stage cardiac failure in humans, Proc. Natl. Acad. Sci. USA, 95, 8801, 10.1073/pnas.95.15.8801

Koontz, 2013, The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression, Dev. Cell, 25, 388, 10.1016/j.devcel.2013.04.021

Lee, 1998, The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression, Mol. Cell Biol., 18, 3120, 10.1128/MCB.18.6.3120

Li, 2014, Alpha-catenins control cardiomyocyte proliferation by regulating yap activity, Circ. Res., 116, 70, 10.1161/CIRCRESAHA.116.304472

Lin, 2014, Strategies for cardiac regeneration and repair, Sci. Transl. Med., 6, 239rv1, 10.1126/scitranslmed.3006681

Lin, 2015, Releasing YAP from an α-catenin trap increases cardiomyocyte proliferation, Circ. Res., 116, 9, 10.1161/CIRCRESAHA.114.305496

Lin, 2014, Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model, Circ. Res., 115, 354, 10.1161/CIRCRESAHA.115.303632

Nakayama, 2007, Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure, J. Clin. Invest., 117, 2431, 10.1172/JCI31060

Oudhoff, 2013, Control of the hippo pathway by Set7-dependent methylation of Yap, Dev. Cell, 26, 188, 10.1016/j.devcel.2013.05.025

Pan, 2010, The hippo signaling pathway in development and cancer, Dev. Cell, 19, 491, 10.1016/j.devcel.2010.09.011

Prasad, 2011, Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution, Gene Ther., 18, 43, 10.1038/gt.2010.105

Schlegelmilch, 2011, Yap1 acts downstream of alpha-catenin to control epidermal proliferation, Cell, 144, 782, 10.1016/j.cell.2011.02.031

Snippert, 2010, Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells, Cell, 143, 134, 10.1016/j.cell.2010.09.016

Söderberg, 2006, Direct observation of individual endogenous protein complexes in situ by proximity ligation, Nat. Methods, 3, 995, 10.1038/nmeth947

Umezawa, 1976, Structures and activities of protease inhibitors of microbial origin, Methods Enzymol., 45, 678, 10.1016/S0076-6879(76)45058-9

Varelas, 2010, The Hippo pathway regulates Wnt/beta-catenin signaling, Dev. Cell, 18, 579, 10.1016/j.devcel.2010.03.007

von Gise, 2012, YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy, Proc. Natl. Acad. Sci. USA, 109, 2394, 10.1073/pnas.1116136109

Walsh, 2010, Cardiomyocyte cell cycle control and growth estimation in vivo—an analysis based on cardiomyocyte nuclei, Cardiovasc. Res., 86, 365, 10.1093/cvr/cvq005

Xin, 2011, Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size, Sci. Signal., 4, ra70, 10.1126/scisignal.2002278

Xin, 2013, Hippo pathway effector Yap promotes cardiac regeneration, Proc. Natl. Acad. Sci. USA, 110, 13839, 10.1073/pnas.1313192110

Yang, 2014, High sensitivity and high Q-factor nanoslotted parallel quadrabeam photonic crystal cavity for real-time and label-free sensing, Appl. Phys. Lett., 105, 063118, 10.1063/1.4867254

Yoshida, 2008, MCAT elements and the TEF-1 family of transcription factors in muscle development and disease, Arterioscler. Thromb. Vasc. Biol., 28, 8, 10.1161/ATVBAHA.107.155788

Zanconato, 2015, Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth, Nat. Cell Biol., 17, 1218, 10.1038/ncb3216

Zhang, 2007, Statistical analysis of the genomic distribution and correlation of regulatory elements in the ENCODE regions, Genome Res., 17, 787, 10.1101/gr.5573107

Zhang, 2014, Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion, J. Biol. Chem., 289, 18681, 10.1074/jbc.M114.554584